Skip to content
Screener

Ashland ASH Life Sciences — PP&E (Net)

Other segment segments

Specialty Additives
$462M
Unallocated And Other
$101M
Personal Care And Household
$100M
Intermediates And Solvents
$30M

Similar metrics at other companies

Costco Wholesale logo
COSTCanada — PP&E (Net)
$3.26B
Accenture logo
ACNAmericas — PP&E (Net)
$561.32M-8.7%
Accenture logo
ACNEMEA — PP&E (Net)
$510.83M-1.7%
AeroVironment logo
AVAVUxs — PP&E (Net)
$5.03M+72.8%
Consolidated Water Company logo
CWCOBulk — PP&E (Net)
$18.54M+3.6%
Consolidated Water Company logo
CWCOCorporate — PP&E (Net)
$201.83K+5.4%

Other financials

Income statement

See full
Revenue$497.0M+7.3%
Gross profit$170.0M+28.8%
Operating income$43.0M+106%
Net income$16.0M+102%
EPS (diluted)$0.35+102%

Balance sheet

See full
Cash & equivalents$440.0M+113%
Total debt$1.5B-0.6%
Total equity$1.9B-1.0%
Total assets$4.6B-0.9%

Cash flow

See full
Operating cash flow$120.0M+4.3%
CapEx$20.0M0.0%
Free cash flow$100.0M+5.3%

Valuation

See full
Market cap$3.32B+40.6%
Enterprise value$4.35B+19.7%
P/E165.9×
P/S1.8×+0.5×

Profitability

See full
Gross margin31.5%+1.4pp
Operating margin4.1%
Net margin1.1%+0.5pp
FCF margin13.6%+9.7pp

Returns & leverage

See full
Return on equity1.1%+0.5pp
Debt / equity0.8×0.0×
Current ratio+0.4×

Where this comes from

Reported directly by Ashland in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Ashland’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:17 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-324226
(In millions - unaudited)June 30 / 2026September 30 / 2025
Unallocated and other1,3481,226
$4,578$4,611
Property, plant and equipment - net
Life Sciences$456$481
Personal Care100101
Specialty Additives462484
Intermediates3030
Unallocated and other101105

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Ashland's life sciences — PP&E (net)?
Ashland (ASH) reported life sciences — PP&E (net) of $456M in Q2 2026.
What does life sciences — PP&E (net) mean?
This represents the book value of the physical infrastructure and manufacturing assets held by the Life Sciences segment, net of accumulated depreciation. It indicates the segment's investment in production capacity and long-term operational capabilities. Changes in this balance reflect capital expenditure trends and the aging profile of the segment's manufacturing footprint.

Ask your AI about Ashland's life sciences — pp&e (net).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude